Company / Free Cash Flow per Share
BeOne Medicines Ltd. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.68
FY2025
5-year range
-$1.37 / $0.68
FY2021-FY2025
Trend
+245.7%
vs FY2024
Sector context
#54 of 192
Health Care
What the data says
Free Cash Flow per Share changed +246% YoY in FY2025, a notable deviation from the 9-year average annual change of -126%.
Based on SEC 10-K filings.
0.68 in FY2025.
Improved from $-1.27 to $0.68 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#54 of 192 in Health CareTop 28% of 192This company $0.68 Sector average $3.32
▼
-79.5% below sector average
Key checks
Key Insights
- BeOne Medicines Ltd.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 245.7% year-over-year.
- Ranks #54 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.68 | +245.7% |
| FY2024 | -$0.47 | +63.3% |
| FY2023 | -$1.27 | +7.1% |
| FY2022 | -$1.37 | -5.4% |
| FY2021 | -$1.29 | +25.9% |
| FY2020 | -$1.75 | -61.6% |
| FY2019 | -$1.08 | -3.7% |
| FY2018 | -$1.04 | -1501.4% |
| FY2017 | -$0.07 | +93.3% |
| FY2016 | -$0.97 | -138.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026